Tumor infiltrating B cells and tertiary lymphoid structures are associated with tumor response to PD-L1 blockade in NSCLC

被引：0
|
作者：
Patil, Namrata S. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5518
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5518
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PD-L1 Expression is Related to Tumor Staging in NSCLC
    Wang, Hangjun
    Agulnik, Jason
    Kasymjanova, Goulnar
    Wang, Anna Y.
    Cohen, Victor
    Small, David
    Pepe, Carmela
    Sakr, Lama
    Fiset, Pierre O.
    Auger, Manon
    Camilleri-Broet, Sophie
    Alameldin, Mona
    Chong, George
    van Kempen, Leon
    Spatz, Alan
    MODERN PATHOLOGY, 2018, 31 : 755 - 755
  • [22] PD-L1 Expression is Related to Tumor Staging in NSCLC
    Wang, Hangjun
    Agulnik, Jason
    Kasymjanova, Goulnar
    Wang, Anna Y.
    Cohen, Victor
    Small, David
    Pepe, Carmela
    Sakr, Lama
    Fiset, Pierre O.
    Auger, Manon
    Camilleri-Broet, Sophie
    Alameldin, Mona
    Chong, George
    van Kempen, Leon
    Spatz, Alan
    LABORATORY INVESTIGATION, 2018, 98 : 755 - 755
  • [23] PD-L1 expression on tumor cells and tumor infiltrating immune cells in Chinese colorectal cancer patients.
    Yang, Jianjun
    Xu, Guanghui
    Zheng, Jiyang
    Du, Kunli
    Zhou, Wei
    Wei, Jiangpeng
    Wang, Haoyu
    Yao, Anliang
    Zhao, Fuyan
    Cong, Yuwei
    Zhao, Xiaochen
    Bai, Yuezong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Accumulation of dysfunctional tumor-infiltrating PD-1+DCs links PD-1/PD-L1 blockade immunotherapeutic response in cervical cancer
    Wang, Yu-meng
    Qiu, Jun-jun
    Qu, Xin-yu
    Peng, Jing
    Lu, Chong
    Zhang, Meng
    Zhang, Ming-Xing
    Qi, Xing-ling
    Lv, Bin
    Guo, Jing-Jing
    Guo, Chen-yan
    Li, Gui-ling
    Hua, Ke-qin
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [25] Parallel genome and transcriptome-wide profiling of PD-L1 expressing tumor and infiltrating immune single cells in NSCLC
    Casonato, Stefano
    Bassi, Giulio
    Bolognesi, Chiara
    Mangano, Chiara
    del Monaco, Valentina
    Buson, Genny
    Forcato, Claudio
    Ferrarini, Alberto
    Bischoff, Farideh
    Medoro, Gianni
    Menaresi, Nicolo
    Fontana, Francesca
    CANCER RESEARCH, 2017, 77
  • [26] Efficacy of Anti-PD-1/PD-L1 Monoclonal Antibody Treatment of Advanced NSCLC on Density and Distribution of Tumor Infiltrating T Cells
    Wang, Y.
    Wo, Y.
    Xue, X.
    Xue, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S333 - S333
  • [27] Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1)
    Kowanetz, Marcin
    Zou, Wei
    Gettinger, Scott N.
    Koeppen, Hartmut
    Kockx, Mark
    Schmid, Peter
    Kadel, Edward E., III
    Wistuba, Ignacio
    Chaft, Jamie
    Rizvi, Naiyer A.
    Spigel, David R.
    Spira, Alexander
    Hirsch, Fred R.
    Cohen, Victor
    Smith, Dustin
    Boyd, Zach
    Miley, Natasha
    Flynn, Susan
    Leveque, Vincent
    Shames, David S.
    Ballinger, Marcus
    Mocci, Simonetta
    Shankar, Geetha
    Funke, Roel
    Hampton, Garret
    Sandler, Alan
    Amler, Lukas
    Mellman, Ira
    Chen, Daniel S.
    Hegde, Priti S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (43) : E10119 - E10126
  • [28] Biological and clinical relevance of PD-L1 expression in tumor and inflammatory cells in NSCLC
    Bais, Carlos
    Morehouse, Chris
    Higgs, Brandon W.
    Marlon, Rebelatto
    Steele, Keith
    Jin, Xiaoping
    Shi, Li
    Korolevich, Susana
    Gupta, Ashok
    Ranade, Koustubh
    CANCER RESEARCH, 2017, 77
  • [29] CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC
    Muto, Satoshi
    Inomata, Sho
    Yamaguchi, Hikaru
    Mine, Hayato
    Takagi, Hironori
    Ozaki, Yuki
    Watanabe, Masayuki
    Inoue, Takuya
    Yamaura, Takumi
    Fukuhara, Mitsuro
    Okabe, Naoyuki
    Matsumura, Yuki
    Hasegawa, Takeo
    Osugi, Jun
    Hoshino, Mika
    Higuchi, Mitsunori
    Shio, Yutaka
    Suzuki, Hiroyuki
    ANTICANCER RESEARCH, 2021, 41 (12) : 6267 - 6272
  • [30] PD-L1 blockade enhances anti-tumor efficacy of NK cells
    Oyer, Jeremiah L.
    Gitto, Sarah B.
    Altomare, Deborah A.
    Copik, Alicja J.
    ONCOIMMUNOLOGY, 2018, 7 (11):
12345